CXCR4 and breast carcinoma: Another study demonstrated that B cells could enhance the metastatic ability of breast cancer cells by activating the CXCR4/SDF1α axis in tumor cells via secreting HSPA4-targeting immunoglobins (Gu et al., 2019).